STOCK TITAN

OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026

OSR Holdings (NASDAQ:OSRH) will present strategic updates at the Emerging Growth Conference on April 1, 2026 at 4:25 p.m. ET.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

OSR Holdings (NASDAQ:OSRH) will present strategic updates at the Emerging Growth Conference on April 1, 2026 at 4:25 p.m. ET. The virtual presentation will review recent milestones including the VXM01 oncology asset and Woori IO noninvasive glucose monitoring platform, followed by Q&A.

A live registration link and archived webcast access are provided for investors and analysts who cannot attend live.

Loading...
Loading translation...
Argus Mar 30 session
+13.84% close to close Open Argus
Details

News Market Reaction – OSRH

On Mar 30, the day this news came out, OSRH closed 13.84% above the previous close.

Data tracked by StockTitan Argus for the Mar 30 session.

Key Figures

Conference date: April 1, 2026 Presentation time: 4:25 p.m. ET
Conference date
April 1, 2026
Emerging Growth Conference virtual presentation
Presentation time
4:25 p.m. ET
Start time for OSRH strategic update and Q&A

Historical Context

5 past events · Latest: Mar 27
5 events
  1. Mar 27

    Analyst flash report

    24h Move
    +5.6%

    Buy-Emerging rating reaffirmed with $10.00 12-month price target and deal highlights.

  2. Mar 23

    Licensing deal update

    24h Move
    +9.6%

    Revised VXM01 license structure with up to $815M milestones and $30M facility.

  3. Mar 19

    Sinopharm NDA signed

    24h Move
    +2.4%

    Mutual NDA with Sinopharm for noninvasive glucose monitoring and China pathway evaluation.

  4. Mar 19

    China opportunity detail

    24h Move
    +2.4%

    Further detail on Sinopharm NDA and large China diabetes and device market potential.

  5. Mar 05

    Nasdaq extension

    24h Move
    +14.7%

    180-day Nasdaq bid-price extension and reiterated VXM01 and device platform priorities.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

oncology, noninvasive glucose monitoring
2 terms
oncology medical
"including its VXM01 oncology asset and Woori IO's noninvasive glucose"
Oncology is the branch of medicine focused on understanding, diagnosing, and treating cancer, including the development and testing of drugs, therapies, and screening methods. It matters to investors because advances, trial results, regulatory approvals, or setbacks in cancer research can dramatically change the value of companies and the size of potential markets—think of oncology news as weather reports that help investors steer financial decisions in a high-stakes field.
noninvasive glucose monitoring medical
"Woori IO's noninvasive glucose monitoring platform - and its outlook for"
A method or device that measures a person’s blood sugar level without piercing the skin or drawing blood, typically using external sensors or light-based techniques. For investors, it matters because successful noninvasive monitoring could unlock a large consumer and medical market by making glucose checks easier, cheaper and more frequent—similar to checking tire pressure without removing the cap—affecting sales, adoption rates and regulatory risk for companies developing the technology.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BELLEVUE, WA / ACCESS Newswire / March 30, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare holding company advancing biomedical innovations to improve health and wellness worldwide, today announced that management will present at the upcoming Emerging Growth Conference. The presentation will provide investors and analysts with an updated overview of the Company's recent strategic milestones - including its VXM01 oncology asset and Woori IO's noninvasive glucose monitoring platform - and its outlook for continued growth.

Virtual Presentation Details

Mr. Tim Smith, Head of Investor Relations, will present the Company's strategic updates, followed by a question-and-answer session, time permitting. Investors are encouraged to submit questions in advance to Questions@EmergingGrowth.com or during the live event and management will address as many questions as possible.

To view the Company's previous presentation, visit: https://www.youtube.com/watch?v=nDaVqSE_GhU&t=651s



Attendees are encouraged to register in advance. For those unable to attend live, an archived webcast will be available at www.EmergingGrowth.com, the Emerging Growth YouTube Channel, and in the "Events & Presentations" section of the Company's website www.OSR-Holdings.com.

About the Emerging Growth Conference

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.

The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.

All sessions will be conducted through video webcasts and will take place in the Eastern time zone.

About OSR Holdings

OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSRH engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes worldwide. Learn more at www.OSR-Holdings.com.

Investor Contact

OSR Holdings, Inc.
Investor Relations
ir@osr-holdings.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable U.S. securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially, including those described in the Company's filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements, except as required by law.

SOURCE: OSR Holdings, Inc.



View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will OSR Holdings (OSRH) present at the Emerging Growth Conference?

OSR Holdings will present on April 1, 2026 at 4:25 p.m. ET. According to OSR Holdings, the virtual session includes strategic updates on VXM01 and Woori IO, followed by a question-and-answer period.

How can investors register to watch OSR Holdings (OSRH) at the April 1, 2026 presentation?

Investors can register via the provided webcast registration link to join live. According to OSR Holdings, registrants receive live access and an archived webcast will be posted after the event for later viewing.

What topics will OSR Holdings (OSRH) cover in the April 1, 2026 Emerging Growth presentation?

The presentation will cover strategic milestones including the VXM01 oncology asset and Woori IO glucose monitoring platform. According to OSR Holdings, management will provide outlook commentary and host a Q&A session time permitting.

Will OSR Holdings (OSRH) allow questions during the Emerging Growth Conference presentation?

Yes, management will take questions during the live session and encourages advance submissions. According to OSR Holdings, investors may email questions in advance or submit them during the webcast for management to address.

Where will the archived OSR Holdings (OSRH) Emerging Growth webcast be available after April 1, 2026?

The archived webcast will be available on Emerging Growth channels and OSR Holdings' website. According to OSR Holdings, archives are posted on EmergingGrowth.com, the Emerging Growth YouTube channel, and the company's Events & Presentations page.

Who will present OSR Holdings' (OSRH) strategic update at the Emerging Growth Conference?

Mr. Tim Smith, Head of Investor Relations, will present the company's strategic update and lead the Q&A. According to OSR Holdings, he will summarize recent milestones and address investor and analyst questions if time allows.

Keep reading